Morpholino

MO1-fbxl22

ID
ZDB-MRPHLNO-140130-3
Name
MO1-fbxl22
Previous Names
None
Target
Sequence
5' - CTTGATCTAGTTCTATGAGATGCAT - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Translation-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-fbxl22
Expressed Gene Anatomy Figures
myh6 Fig. S9 from Spaich et al., 2012
myh7 Fig. S9 from Spaich et al., 2012
myl7 Fig. S9 from Spaich et al., 2012
nppa Fig. S9 from Spaich et al., 2012
Phenotype
Phenotype resulting from MO1-fbxl22
Phenotype Fish Figures
cardiac muscle contraction decreased process quality, abnormal WT + MO1-fbxl22 Fig. 8,  Fig. S8 from Spaich et al., 2012
heart decreased contractility, abnormal WT + MO1-fbxl22 Fig. 8 from Spaich et al., 2012
heart edematous, abnormal WT + MO1-fbxl22 Fig. 8,  Fig. S8 from Spaich et al., 2012
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process decreased occurrence, abnormal WT + MO1-fbxl22 Fig. 8 from Spaich et al., 2012
skeletal muscle contraction decreased process quality, abnormal WT + MO1-fbxl22 Fig. M4 from Spaich et al., 2012
Phenotype of all Fish created by or utilizing MO1-fbxl22
Phenotype Fish Conditions Figures
heart decreased contractility, abnormal WT + MO1-fbxl22 standard conditions Fig. 8 from Spaich et al., 2012
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process decreased occurrence, abnormal WT + MO1-fbxl22 standard conditions Fig. 8 from Spaich et al., 2012
cardiac muscle contraction decreased process quality, abnormal WT + MO1-fbxl22 standard conditions Fig. 8,  Fig. S8 from Spaich et al., 2012
skeletal muscle contraction decreased process quality, abnormal WT + MO1-fbxl22 standard conditions Fig. M4 from Spaich et al., 2012
heart edematous, abnormal WT + MO1-fbxl22 standard conditions Fig. 8,  Fig. S8 from Spaich et al., 2012
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process decreased occurrence, abnormal WT + MO1-fbxl22 chemical treatment: drug Fig. 8 from Spaich et al., 2012
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.